image
mobile_image
image_caption
eyebrow
headline
VELSIPITY has demonstrated safety data in clinical trials
headline2
content
content2
buttons
disclaimer
eyebrow
headline
headline2
content
VELSIPITY should not be taken by patients with certain cardiac conditions such as prior heart attack, chest pain, stroke or heart failure. VELSIPITY can cause serious side effects including infections (some life threatening), a slow heart rate known as bradyarrhythmia, liver problems, increased blood pressure, a vision problem called macular edema, certain types of skin cancer, swelling and narrowing of the blood vessels in your brain, or shortness of breath.
See full Important Safety Information at the bottom of this page.
content2
buttons
disclaimer
headline
The safety of VELSIPITY has been studied in a clinical program with 577 participants taking VELSIPITY across 3 placebo-controlled studies.
headline2
content
card_identifier
heading
The most common side effects occurring in ≥5% of subjects taking VELSIPITY were headache, elevated liver tests, and dizziness.
body
cta
card_identifier
heading
Your doctor will talk to you about the possibility of side effects, potential for serious infections, and whether VELSIPITY is appropriate for you.
body
cta
eyebrow
headline
headline2
content
Across two 12-week studies, 6% of people taking VELSIPITY discontinued due to side effects. In the 52-week study, 4% of people taking VELSIPITY discontinued due to side effects.
content2
buttons
Cta_brightcove_account_id
Cta_brightcove_video_id
disclaimer
icon
headline
Learn more about VELSIPITY
subheadline
disclaimer
buttons
image
Mobile_image
eyebrow
headline
Stay informed about VELSIPITY
subheadline
content
buttons
content2
disclaimer
Image_disclaimer
Brightcove_video_id
Brightcove_account_id